{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:07:32Z","timestamp":1762340852573},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.surg.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T17:10:35Z","timestamp":1446484235000},"page":"728-735","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)"],"prefix":"10.1016","volume":"159","author":[{"given":"Juan Torres","family":"Melero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco G.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro Morales","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Carmona-Saez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Garcia Puche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul. H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2015.09.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/782890","article-title":"Colorectal cancer: prevention and management of metastatic disease","volume":"24","author":"Sugarbaker","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.surg.2015.09.013_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/SLA.0000000000000582","article-title":"Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers","volume":"261","author":"Elias","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00384-014-1907-x","article-title":"Management of peritoneal carcinomatosis from colorectal cancer: review of the literature","volume":"29","author":"Vallicelli","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.surg.2015.09.013_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib5","first-page":"77","article-title":"Current management of peritoneal carcinomatosis from colorectal cancer","volume":"68","author":"Ceelen","year":"2013","journal-title":"Minerva Chir"},{"key":"10.1016\/j.surg.2015.09.013_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jso.21484","article-title":"Surgical responsibilities in the management of peritoneal carcinomatosis","volume":"101","author":"Sugarbaker","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.amjsurg.2014.11.004","article-title":"Treatment of carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in adolescents and young adults","volume":"209","author":"Oyeniyi","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/07357907.2012.654871","article-title":"Peritoneal carcinomatosis: cytoreductive surgery and HIPEC\u2014overview and basics","volume":"30","author":"Br\u00fccher","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.surg.2015.09.013_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jso.23722","article-title":"American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer","volume":"110","author":"Esquivel","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib12","first-page":"459","article-title":"Updated treatment of peritoneal carcinomas: a review","volume":"62","author":"Deraco","year":"2007","journal-title":"Minerva Chir"},{"key":"10.1016\/j.surg.2015.09.013_bib13","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1245\/s10434-014-3506-z","article-title":"A\u00a0simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases","volume":"21","author":"Elias","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-13-67","article-title":"A\u00a0prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial","volume":"13","author":"Glockzin","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib15","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3892\/ijo.2015.2824","article-title":"Importance of circulating tumor cells in newly diagnosed colorectal cancer","volume":"46","author":"VanDalum","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/10408363.2014.896316","article-title":"Circulating tumor cells as promising novel biomarkers in solid cancers","volume":"51","author":"Lianidou","year":"2014","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.surg.2015.09.013_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/erm.13.7","article-title":"Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies","volume":"13","author":"Nadal","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.surg.2015.09.013_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clcc.2014.12.002","article-title":"Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer","volume":"14","author":"Manzoni","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.soc.2012.12.007","article-title":"Colorectal cancer metastases: a surgical perspective","volume":"22","author":"Sugarbaker","year":"2013","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.surg.2015.09.013_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002689900560","article-title":"Second-look surgery alter cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic factors","volume":"23","author":"Portilla","year":"1999","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clcc.2012.01.001","article-title":"Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer","volume":"11","author":"Weber","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib23","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/bcr3180","article-title":"Biomarkers characterization of circulating tumour cells in breast cancer patients","volume":"14","author":"Nadal","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.surg.2015.09.013_bib24","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.3748\/wjg.v20.i35.12493","article-title":"Current treatment options for colon cancer peritoneal carcinomatosis","volume":"20","author":"Aoyagi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2015.09.013_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00104-014-2724-z","article-title":"Cytoreductive surgery for malignant peritoneal tumors","volume":"86","author":"Piso","year":"2015","journal-title":"Chirurg"},{"key":"10.1016\/j.surg.2015.09.013_bib26","first-page":"9286","article-title":"Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer","volume":"20","author":"Sugarbaker","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2015.09.013_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/bjc.2014.369","article-title":"Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review","volume":"111","author":"Sloothaak","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.suronc.2014.03.004","article-title":"Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective","volume":"23","author":"Kitayama","year":"2014","journal-title":"Surg Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib31","doi-asserted-by":"crossref","first-page":"e40476","DOI":"10.1371\/journal.pone.0040476","article-title":"Molecular characterization of circulating tumor cells in human metastatic colorectal cancer","volume":"7","author":"Barbaz\u00e1n","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2015.09.013_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/etm.2012.540","article-title":"Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy","volume":"4","author":"Serrano","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.surg.2015.09.013_bib33","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjc.2015.63","article-title":"Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents","volume":"112","author":"Crespo","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2015.09.013_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/gm477","article-title":"Circulating tumor cells and DNA as liquid biopsies","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.surg.2015.09.013_bib35","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumour cells to tumour response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"31","author":"Cohen","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2015.09.013_bib36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00268-010-0443-2","article-title":"The effect of obstruction and perforation on colorectal cancer disease-free survival","volume":"34","author":"Ho","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2015.09.013_bib37","first-page":"3905","article-title":"Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer","volume":"33","author":"Kuboki","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2015.09.013_bib38","first-page":"113","article-title":"Preliminary finding: detection of circulating cancer cells in blood from a patient with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"2","author":"Castro","year":"2012","journal-title":"Surgery Curr Res"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015008016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015008016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T02:03:09Z","timestamp":1567303389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606015008016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0039606015008016"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2015.09.013","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}